Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 12, 2000, Pages 4650-4656

  Hunt, Penelope J ^a   Gurnell, Eleanor M ^b   Huppert, Felicia A ^c   Richards, Christine ^b   Prevost, A Toby ^d   Wass, John A H ^a   Herbert, Joseph ^d   Chatterjee, V Krishna K ^b,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADDISON DISEASE; ADULT; AGED; ANDROGEN SYNTHESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; MALE; MOOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF ESTEEM; TREATMENT OUTCOME; WELLBEING;

ADDISON DISEASE; ADULT; AFFECT; AGED; BODY COMPOSITION; BONE DENSITY; COGNITION; CROSS-OVER STUDIES; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HORMONE REPLACEMENT THERAPY; HORMONES; HUMANS; MALE; MIDDLE AGED; SEXUAL BEHAVIOR;

EID: 0034487898     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.12.4650     Document Type: Article

References (42)

1. Isolierung neuen, physiologisch unwirksamen Sterindervates aus Mannerharn, seine verknupfung mit dehdroandrosterone und androsteron
2. 5-derivatives in rat and monkey brain
3. Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice
4. Dehydroepiandrosterone, its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures
5. Dehydroepiandrosterone, its sulfate enhance memory retention in mice
6. Glucocorticoid-induced impairment in declarative memory performance in adult humans
7. Hippocampal aging and adrenocorticoids: Quantitative correlations
8. Cortisol levels during human aging predict hippocampal atrophy and memory deficits
9. Neuropsychiatric manifestations of patients with Cushing's syndrome: Relationship to cortisol and adrenocorticotrophic hormone levels
10. Dehydroepiandrosterone prevents dexamethasone-induced hypertension in rats
11. Dehydroepiandrosterone (DHEA) antagonises the neurotoxic effects of corticosterone, translocation of SAPK 3 in hippocampal primary cultures
12. The adrenarche: Prolactin, gonadotropins, adrenal androgens and cortisol
13. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood
14. A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease
15. Physiological importance of dehydroepiandrosterone
16. Postmenopausal bone loss in rheumatoid arthritis: Effect of estrogens and androgens
17. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age
18. The effect of six months treatment with a 100mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women
19. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women
20. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-1 and decreases high-density lipoprotein: A six month trial
21. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina and endometrium in postmenopausal women
22. Double-blind treatment of major depression with dehydroepiandrosterone
23. Quality of life in patients with Addison's disease: Effects of different cortisol replacement modes
24. Assessing the potential for finetuning the management of Addison's disease/steroid replacement therapy
25. The effects of recombinant human IGF-1 administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-1, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus
26. Adrenal secretion during major depression in 8- to 16- year olds. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation
27. Cortisol, dehydroepiandrosterone (DHEA), DHEA sulfate in the cerebrospinal fluid of man: Relation to blood levels and the effects of age
28. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
29. The factor structure of the General Health Questionnaire (GHQ-30): A reliability study on 6317 community residents
30. The GRISS: A psychometric instrument for the assessment of sexual dysfunction
31. Oral dehydroepiandrosterone for adrenal androgen replacement: Pharmacokinetics and peripheral conversion to androgens and estrogens in young females after dexamethasone suppression
32. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans
33. Biotransformation of oral dehydroepiandrosterone in elderly men: Significant increase in circulating estrogens
34. Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone
35. Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats
36. Dehydroepiandrosterone replacement in women with adrenal insufficiency
37. Clinical review: Androgens and the postmenopausal woman
38. A prospective study on cortisol, dehydroepiandrosterone sulfate and cognitive function in the elderly
39. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge Study to a sociobiomedical issue